Education
About Us
Working with TipRanks
Follow Us
Diagnos (TSE:ADK)
:ADK
ADK Stock Chart & Stats
C$0.36
C$0.03(9.38%)
At close: 4:00 PM EST
C$0.36
C$0.03(9.38%)
Day’s Range― - ―
52-Week RangeC$0.18 - C$0.42
Previous CloseN/A
Volume270.50K
Average Volume (3M)342.67K
Market Cap
C$36.12M
Enterprise ValueC$32.46M
Total Cash (Recent Filing)C$737.25K
Total Debt (Recent Filing)C$2.39M
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Mar 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding120,412,550
10 Day Avg. Volume531,548
30 Day Avg. Volume342,665
Financial Highlights & Ratios
PEG Ratio-0.45
Price to Book (P/B)-6.56
Price to Sales (P/S)117.69
P/FCF Ratio-9.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Modest DeleveragingThe balance sheet notes that total debt is lower than the most recent annual period, indicating management has reduced leverage. Sustained deleveraging improves financing optionality and lowers interest burden, which can materially extend runway and reduce downside over months.
Lean Operating FootprintA very small workforce (16 employees) implies a lean cost base and operational flexibility. When cash is constrained, a compact team helps preserve cash burn, enables faster pivots, and reduces fixed overhead — durable advantages for surviving turnaround phases.
Exposure To Healthcare Information ServicesOperating in medical/healthcare information services places the company in a sector with secular demand for digitization, data analytics, and regulatory compliance support. These structural tailwinds can sustain long-term TAM expansion if product-market fit and execution improve.
Bears Say
Declining Revenue And Deep Negative MarginsRevenue decline combined with very negative gross, EBITDA, and net margins indicates the core business does not cover costs. Persistently poor profitability undermines reinvestment capacity, impairs competitive positioning, and makes reaching self-sustaining operations difficult without structural change.
Negative Shareholders' EquityNegative equity signals accumulated losses and constrains access to traditional financing. It increases the likelihood of dilutive capital raises or covenant pressure, complicates M&A or partnership options, and materially raises insolvency risk if losses persist.
Sustained Cash Burn And Weak Cash GenerationLarge negative operating and free cash flows show the business is consuming cash rather than funding itself. Continued cash burn shortens runway, forces reliance on external funding, and limits the company's ability to invest in growth or withstand market shocks over the coming months.
Diagnos News
ADK FAQ
What was Diagnos’s price range in the past 12 months?
Diagnos lowest stock price was C$0.18 and its highest was C$0.41 in the past 12 months.
What is Diagnos’s market cap?
Diagnos’s market cap is C$36.12M.
When is Diagnos’s upcoming earnings report date?
Diagnos’s upcoming earnings report date is Mar 04, 2026 which is in 11 days.
How were Diagnos’s earnings last quarter?
Diagnos released its earnings results on Nov 20, 2025. The company reported -C$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.011.
Is Diagnos overvalued?
According to Wall Street analysts Diagnos’s price is currently Overvalued.
Does Diagnos pay dividends?
Diagnos does not currently pay dividends.
What is Diagnos’s EPS estimate?
Diagnos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Diagnos have?
Diagnos has 120,412,550 shares outstanding.
What happened to Diagnos’s price movement after its last earnings report?
Diagnos reported an EPS of -C$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.226%.
Which hedge fund is a major shareholder of Diagnos?
Currently, no hedge funds are holding shares in TSE:ADK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Diagnos Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.46%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
86.04%
Trailing 12-Months
Company Description
Diagnos
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Technical Analysis
Rocket Doctor AI
―
Comprehensive Healthcare Systems Inc
―
UniDoc Health Corp
―
PanGenomic Health, Inc. Class A
―
DiagnaMed Holdings Corp.
―
Options Prices
Currently, No data available
---